4//SEC Filing
Bertolino Arthur Peter 4
Accession 0001123292-18-000972
CIK 0001355250other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 4:32 PM ET
Size
7.4 KB
Accession
0001123292-18-000972
Insider Transaction Report
Form 4
Bertolino Arthur Peter
Pres. & Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2018-09-01+617,839→ 617,839 totalExercise: $0.40Exp: 2028-09-01→ Class A Common Stock (617,839 underlying) - Award
Class A Common Stock
2018-09-01+1,066,667→ 2,699,873 total
Footnotes (1)
- [F1]The restricted stock and stock options vest upon the earliest of (i) 50% on September 1, 2019 and 50% on September 1, 2020; (ii) the Company's common stock closes above $3.00 per share (as may be adjusted for any stock splits or similar actions); (iii) the commencement of trading of the Company's common stock on a national securities exchange; or (iv) upon a change of control of the Company, as defined in the Company's 2016 Equity Incentive Plan.
Documents
Issuer
Innovation Pharmaceuticals Inc.
CIK 0001355250
Entity typeother
Related Parties
1- filerCIK 0001426344
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 4:32 PM ET
- Size
- 7.4 KB